250 related articles for article (PubMed ID: 29922755)
1. Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel diseases. A case-control study.
Rosania R; Von Arnim U; Link A; Rajilic-Stojanovic M; Franck C; Canbay A; Malfertheiner P; Venerito M
J Gastrointestin Liver Dis; 2018 Jun; 27(2):119-125. PubMed ID: 29922755
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching.
Parente F; Molteni P; Bollani S; Maconi G; Vago L; Duca PG; Rembacken B; Axon AT; Bianchi Porro G
Scand J Gastroenterol; 1997 Nov; 32(11):1140-6. PubMed ID: 9399396
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor?
Väre PO; Heikius B; Silvennoinen JA; Karttunen R; Niemelä SE; Lehtola JK; Karttunen TJ
Scand J Gastroenterol; 2001 Dec; 36(12):1295-300. PubMed ID: 11761020
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study.
Ding ZH; Xu XP; Wang TR; Liang X; Ran ZH; Lu H
PLoS One; 2021; 16(3):e0248427. PubMed ID: 33711050
[TBL] [Abstract][Full Text] [Related]
5. [The prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease, a multicenter study].
Song MJ; Park DI; Hwang SJ; Kim ER; Kim YH; Jang BI; Lee SH; Ji JS; Shin SJ
Korean J Gastroenterol; 2009 Jun; 53(6):341-7. PubMed ID: 19556840
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of Helicobacter pylori gastritis in newly diagnosed children with inflammatory bowel disease.
Roka K; Roubani A; Stefanaki K; Panayotou I; Roma E; Chouliaras G
Helicobacter; 2014 Oct; 19(5):400-5. PubMed ID: 24827117
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Pearce CB; Duncan HD; Timmis L; Green JR
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.
Tepler A; Narula N; Peek RM; Patel A; Edelson C; Colombel JF; Shah SC
Aliment Pharmacol Ther; 2019 Jul; 50(2):121-131. PubMed ID: 31165513
[TBL] [Abstract][Full Text] [Related]
9. Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
Lin KD; Chiu GF; Waljee AK; Owyang SY; El-Zaatari M; Bishu S; Grasberger H; Zhang M; Wu DC; Kao JY
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1991-1999. PubMed ID: 30580094
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
11. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role.
Prónai L; Schandl L; Orosz Z; Magyar P; Tulassay Z
Helicobacter; 2004 Jun; 9(3):278-83. PubMed ID: 15165265
[TBL] [Abstract][Full Text] [Related]
12. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis.
Castaño-Rodríguez N; Kaakoush NO; Lee WS; Mitchell HM
Gut; 2017 Feb; 66(2):235-249. PubMed ID: 26508508
[TBL] [Abstract][Full Text] [Related]
13. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease.
Halme L; Rautelin H; Leidenius M; Kosunen TU
J Clin Pathol; 1996 Jan; 49(1):65-7. PubMed ID: 8666689
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease.
Sonnenberg A; Genta RM
Aliment Pharmacol Ther; 2012 Feb; 35(4):469-76. PubMed ID: 22221289
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine.
el-Omar E; Penman I; Cruikshank G; Dover S; Banerjee S; Williams C; McColl KE
Gut; 1994 Oct; 35(10):1385-8. PubMed ID: 7959192
[TBL] [Abstract][Full Text] [Related]
16. Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer.
Fujita Y; Tominaga K; Tanaka T; Sugaya T; Yoshihara S
BMC Gastroenterol; 2021 Nov; 21(1):424. PubMed ID: 34758726
[TBL] [Abstract][Full Text] [Related]
17. Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with
Murad H; Rafeeq M; Mosli M; Gari M; Basheikh M
J Int Med Res; 2021 Nov; 49(11):3000605211060648. PubMed ID: 34851775
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between
Zhong Y; Zhang Z; Lin Y; Wu L
Arch Iran Med; 2021 Apr; 24(4):317-325. PubMed ID: 34196192
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population.
Garza-González E; Pérez-Pérez GI; Mendoza-Ibarra SI; Flores-Gutiérrez JP; Bosques-Padilla FJ
Int J Immunogenet; 2010 Oct; 37(5):355-9. PubMed ID: 20518842
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection and inflammatory bowel disease: is there a link?
Papamichael K; Konstantopoulos P; Mantzaris GJ
World J Gastroenterol; 2014 Jun; 20(21):6374-85. PubMed ID: 24914359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
